# Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery

> **NCT00654992** · PHASE2,PHASE3 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 71 (actual)

## Conditions studied

- Kidney Failure, Acute

## Interventions

- **DRUG:** Erythropoietin-Beta
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT00654992
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-02
- **Final completion:** 2009-02
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2009-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654992, "Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00654992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*